Cervical Cancer Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
The global cervical cancer diagnostics market size reached US$ 7.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.4 Billion by 2028, exhibiting a growth rate (CAGR) of 5.6% during 2022-2028.
Cervical cancer diagnostics rely on a series of advanced laboratory tests, tools and procedures to evaluate abnormal cells or strains of the human papillomavirus (HPV). They are performed by taking a sample of the tissue obtained through conization, punch biopsy, endocervical curettage and the electrical wire loop for a thorough examination of the cervix during colposcopy. After detection, tests like blood, chest X-ray, body computed tomography (CT) scan, magnetic resonance imaging (MRI), positron emission tomography (PET) scan and visual examination of bladder and rectum are conducted to determine the disease stage.
A considerable rise in the number of individuals diagnosed with sexually transmitted infections (STIs), such as syphilis, chlamydia, gonorrhea and acquired immune deficiency syndrome (HIV/AIDS), is escalating the risk of HPV infection worldwide. This, along with the growing number of smokers, which increases the chances of developing cervical cancer, represents one of the key factors bolstering the market growth. Furthermore, the rising awareness about early diagnosis is encouraging the adoption of HPV home testing kits that provide quick and accurate test results. The presence of favorable reimbursement policies also supports the market growth. Apart from this, rising preferences for personalized treatment plans are escalating the demand for cervical cancer diagnostics. Additionally, the availability of a range of other treatment options, including surgery, radiation therapy, chemotherapy, cone biopsy, immunotherapy and trachelectomy, is contributing to the market growth. Moreover, the growing emphasis on developing low-cost and efficient testing products is anticipated to fuel the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global cervical cancer diagnostics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on test type and age group.
Breakup by Test Type:
Pap Testing
HPV Testing
Cervical Biopsies
Colposcopy
Others
Breakup by Age Group:
20 to 35 years
Above 35 years
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arbor Vita Corporation, Becton, Dickinson and Company, Cooper Surgical Inc., F. Hoffmann-La Roche AG, Guided Therapeutics Inc., Hologic Inc., Qiagen, Quest Diagnostics Incorporated and Siemens Healthcare GmbH.
Key Questions Answered in This Report
1. How big is the global cervical cancer diagnostics market?
2. What is the expected growth rate of the global cervical cancer diagnostics market during 2023-2028?
3. What are the key factors driving the global cervical cancer diagnostics market?
4. What has been the impact of COVID-19 on the global cervical cancer diagnostics market?
5. What is the breakup of the global cervical cancer diagnostics market based on the test type?
6. What are the key regions in the global cervical cancer diagnostics market?
7. Who are the key players/companies in the global cervical cancer diagnostics market?
Cervical cancer diagnostics rely on a series of advanced laboratory tests, tools and procedures to evaluate abnormal cells or strains of the human papillomavirus (HPV). They are performed by taking a sample of the tissue obtained through conization, punch biopsy, endocervical curettage and the electrical wire loop for a thorough examination of the cervix during colposcopy. After detection, tests like blood, chest X-ray, body computed tomography (CT) scan, magnetic resonance imaging (MRI), positron emission tomography (PET) scan and visual examination of bladder and rectum are conducted to determine the disease stage.
A considerable rise in the number of individuals diagnosed with sexually transmitted infections (STIs), such as syphilis, chlamydia, gonorrhea and acquired immune deficiency syndrome (HIV/AIDS), is escalating the risk of HPV infection worldwide. This, along with the growing number of smokers, which increases the chances of developing cervical cancer, represents one of the key factors bolstering the market growth. Furthermore, the rising awareness about early diagnosis is encouraging the adoption of HPV home testing kits that provide quick and accurate test results. The presence of favorable reimbursement policies also supports the market growth. Apart from this, rising preferences for personalized treatment plans are escalating the demand for cervical cancer diagnostics. Additionally, the availability of a range of other treatment options, including surgery, radiation therapy, chemotherapy, cone biopsy, immunotherapy and trachelectomy, is contributing to the market growth. Moreover, the growing emphasis on developing low-cost and efficient testing products is anticipated to fuel the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global cervical cancer diagnostics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on test type and age group.
Breakup by Test Type:
Pap Testing
HPV Testing
Cervical Biopsies
Colposcopy
Others
Breakup by Age Group:
20 to 35 years
Above 35 years
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arbor Vita Corporation, Becton, Dickinson and Company, Cooper Surgical Inc., F. Hoffmann-La Roche AG, Guided Therapeutics Inc., Hologic Inc., Qiagen, Quest Diagnostics Incorporated and Siemens Healthcare GmbH.
Key Questions Answered in This Report
1. How big is the global cervical cancer diagnostics market?
2. What is the expected growth rate of the global cervical cancer diagnostics market during 2023-2028?
3. What are the key factors driving the global cervical cancer diagnostics market?
4. What has been the impact of COVID-19 on the global cervical cancer diagnostics market?
5. What is the breakup of the global cervical cancer diagnostics market based on the test type?
6. What are the key regions in the global cervical cancer diagnostics market?
7. Who are the key players/companies in the global cervical cancer diagnostics market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL CERVICAL CANCER DIAGNOSTICS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY TEST TYPE
6.1 Pap Testing
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 HPV Testing
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Cervical Biopsies
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Colposcopy
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 MARKET BREAKUP BY AGE GROUP
7.1 20 to 35 years
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Above 35 years
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY REGION
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 SWOT ANALYSIS
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 VALUE CHAIN ANALYSIS
11 PORTERS FIVE FORCES ANALYSIS
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 PRICE ANALYSIS
13 COMPETITIVE LANDSCAPE
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Abbott Laboratories
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 Arbor Vita Corporation
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.3 Becton, Dickinson and Company
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.3.4 SWOT Analysis
13.3.4 Cooper Surgical Inc.
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.5 F. Hoffmann-La Roche AG
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.6 Guided Therapeutics Inc.
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 SWOT Analysis
13.3.7 Hologic Inc.
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.7.4 SWOT Analysis
13.3.8 Qiagen
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.8.4 SWOT Analysis
13.3.9 Quest Diagnostics Incorporated
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
13.3.10 Siemens Healthcare GmbH
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL CERVICAL CANCER DIAGNOSTICS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY TEST TYPE
6.1 Pap Testing
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 HPV Testing
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Cervical Biopsies
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Colposcopy
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 MARKET BREAKUP BY AGE GROUP
7.1 20 to 35 years
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Above 35 years
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY REGION
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 SWOT ANALYSIS
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 VALUE CHAIN ANALYSIS
11 PORTERS FIVE FORCES ANALYSIS
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 PRICE ANALYSIS
13 COMPETITIVE LANDSCAPE
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Abbott Laboratories
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 Arbor Vita Corporation
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.3 Becton, Dickinson and Company
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.3.4 SWOT Analysis
13.3.4 Cooper Surgical Inc.
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.5 F. Hoffmann-La Roche AG
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.6 Guided Therapeutics Inc.
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 SWOT Analysis
13.3.7 Hologic Inc.
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.7.4 SWOT Analysis
13.3.8 Qiagen
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.8.4 SWOT Analysis
13.3.9 Quest Diagnostics Incorporated
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
13.3.10 Siemens Healthcare GmbH
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 SWOT Analysis
LIST OF TABLES
Table 1: Global: Cervical Cancer Diagnostics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Cervical Cancer Diagnostics Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
Table 3: Global: Cervical Cancer Diagnostics Market Forecast: Breakup by Age Group (in Million US$), 2023-2028
Table 4: Global: Cervical Cancer Diagnostics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 5: Global: Cervical Cancer Diagnostics Market: Competitive Structure
Table 6: Global: Cervical Cancer Diagnostics Market: Key Players
Table 1: Global: Cervical Cancer Diagnostics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Cervical Cancer Diagnostics Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
Table 3: Global: Cervical Cancer Diagnostics Market Forecast: Breakup by Age Group (in Million US$), 2023-2028
Table 4: Global: Cervical Cancer Diagnostics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 5: Global: Cervical Cancer Diagnostics Market: Competitive Structure
Table 6: Global: Cervical Cancer Diagnostics Market: Key Players
LIST OF FIGURES
Figure 1: Global: Cervical Cancer Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Cervical Cancer Diagnostics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Cervical Cancer Diagnostics Market: Breakup by Test Type (in %), 2022
Figure 5: Global: Cervical Cancer Diagnostics Market: Breakup by Age Group (in %), 2022
Figure 6: Global: Cervical Cancer Diagnostics Market: Breakup by Region (in %), 2022
Figure 7: Global: Cervical Cancer Diagnostics (Pap Testing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 8: Global: Cervical Cancer Diagnostics (Pap Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 9: Global: Cervical Cancer Diagnostics (HPV Testing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Cervical Cancer Diagnostics (HPV Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Cervical Cancer Diagnostics (Cervical Biopsies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Cervical Cancer Diagnostics (Cervical Biopsies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Cervical Cancer Diagnostics (Colposcopy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Cervical Cancer Diagnostics (Colposcopy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Cervical Cancer Diagnostics (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Cervical Cancer Diagnostics (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Cervical Cancer Diagnostics (20 to 35 years) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Cervical Cancer Diagnostics (20 to 35 years) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Cervical Cancer Diagnostics (Above 35 years) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Cervical Cancer Diagnostics (Above 35 years) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: North America: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: North America: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: United States: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: United States: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Canada: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Canada: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Asia-Pacific: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Asia-Pacific: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: China: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: China: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Japan: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Japan: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: India: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: India: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: South Korea: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: South Korea: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Australia: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Australia: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Indonesia: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Indonesia: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Others: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Others: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Europe: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Europe: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Germany: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Germany: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: France: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: France: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: United Kingdom: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: United Kingdom: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Italy: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Italy: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Spain: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Spain: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Russia: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Russia: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Others: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Others: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Latin America: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Latin America: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Brazil: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Brazil: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Mexico: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Mexico: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Others: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Others: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Middle East and Africa: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Middle East and Africa: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Middle East and Africa: Cervical Cancer Diagnostics Market: Breakup by Country (in %), 2022
Figure 70: Global: Cervical Cancer Diagnostics Industry: SWOT Analysis
Figure 71: Global: Cervical Cancer Diagnostics Industry: Value Chain Analysis
Figure 72: Global: Cervical Cancer Diagnostics Industry: Porter's Five Forces Analysis
Figure 1: Global: Cervical Cancer Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Cervical Cancer Diagnostics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Cervical Cancer Diagnostics Market: Breakup by Test Type (in %), 2022
Figure 5: Global: Cervical Cancer Diagnostics Market: Breakup by Age Group (in %), 2022
Figure 6: Global: Cervical Cancer Diagnostics Market: Breakup by Region (in %), 2022
Figure 7: Global: Cervical Cancer Diagnostics (Pap Testing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 8: Global: Cervical Cancer Diagnostics (Pap Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 9: Global: Cervical Cancer Diagnostics (HPV Testing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Cervical Cancer Diagnostics (HPV Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Cervical Cancer Diagnostics (Cervical Biopsies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Cervical Cancer Diagnostics (Cervical Biopsies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Cervical Cancer Diagnostics (Colposcopy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Cervical Cancer Diagnostics (Colposcopy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Cervical Cancer Diagnostics (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Cervical Cancer Diagnostics (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Cervical Cancer Diagnostics (20 to 35 years) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Cervical Cancer Diagnostics (20 to 35 years) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Cervical Cancer Diagnostics (Above 35 years) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Cervical Cancer Diagnostics (Above 35 years) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: North America: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: North America: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: United States: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: United States: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Canada: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Canada: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Asia-Pacific: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Asia-Pacific: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: China: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: China: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Japan: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Japan: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: India: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: India: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: South Korea: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: South Korea: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Australia: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Australia: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Indonesia: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Indonesia: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Others: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Others: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Europe: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Europe: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Germany: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Germany: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: France: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: France: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: United Kingdom: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: United Kingdom: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Italy: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Italy: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Spain: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Spain: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Russia: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Russia: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Others: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Others: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Latin America: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Latin America: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Brazil: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Brazil: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Mexico: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Mexico: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Others: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Others: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Middle East and Africa: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Middle East and Africa: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Middle East and Africa: Cervical Cancer Diagnostics Market: Breakup by Country (in %), 2022
Figure 70: Global: Cervical Cancer Diagnostics Industry: SWOT Analysis
Figure 71: Global: Cervical Cancer Diagnostics Industry: Value Chain Analysis
Figure 72: Global: Cervical Cancer Diagnostics Industry: Porter's Five Forces Analysis
